Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Improved Finasteride delivery for hair loss treatment.

Ultrasound alone isn't enough to diagnose PCOS.

The F9 formulation of Finasteride tablets, using Eudragit, successfully controlled drug release.

The meeting established common practices for hair restoration surgery.

Different forms of FGF5 either promote or inhibit hair growth.

The method effectively detects banned substances in urine for sports antidoping.

A protein made in a plant stopped hair growth in mice.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

Certain genetic variations in IGF2BP2 and IGFBP3 are linked to a higher risk of PCOS.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Method detects finasteride in plasma and semen with high sensitivity and accuracy.

Frontal fibrosing alopecia can affect African men and may be underdiagnosed.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

New method measures finasteride in plasma, finds two formulations bioequivalent.

Arabidopsis Formin 2 stabilizes actin filaments, affecting cell-to-cell movement and virus susceptibility.

More research is needed to confirm sperm DNA fragmentation as a reliable tool for diagnosing male infertility.

Ferric carboxymaltose effectively improved iron deficiency anemia symptoms and increased hemoglobin and ferritin levels.

The new hydrogel improves soft tissue repair and healing.

Disabling the FGF5 gene in sheep leads to longer wool.

Hair restoration surgeons must understand the differences between CTE and FPHL for accurate diagnosis and treatment.

Targeting Hedgehog signaling may help treat ligamentum flavum fibrosis.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Sfrp2 increases during hair follicle catagen phase and slows keratinocyte growth.

Ishige sinicola extract may help prevent muscle atrophy through its antioxidant and anti-inflammatory effects.

FUE with DHI effectively restores natural hair growth in difficult scalp areas.

Frontal fibrosing alopecia and vitiligo might be linked by similar immune issues.